Max Planck Institute for Molecular Genetics awarded Geneart a contract to produce genes and gene variants for the project “Mutanom - Systems Biology of Genetic Diseases.” Genes will be developed over the next two...
Merck KGaA, Darmstadt, Germany, said today it will carry out a €150 million ($168 million) expansion of its biologics manufacturing site at Aubonne, Switzerland, designed to help meet the growing demand for treatments by...
A novel method for characterizing protein interactions
CMC Biologics have inked an agreement with OncoSynergy to develop materials for IND-enabling toxicology studies and Phase I clinical trials.
CytoSorbents has been awarded a $1M Small Business Technology Transfer (STTR) contract to support the development of a purification process that will allow the production of a "universal" blood plasma that doesn’t require cross-matching; CytoSorbents will work with Penn State University on the project
Cruiserath plant in Dublin set to close by end of 2015, idling all 130 workers; another 30 to be axed at Swords.
The site handles microparticles, nanoparticles, liposomes, and implants for ER delivery of small molecules, peptides, proteins, and antibodies.
Sartorius Stedim Biotech signed a deal to acquire the majority stake in AllPure Technologies.
Please wait while you are redirected to the right page...